CBD/Hemp Legalization News Politics

FDA sets first hearing on CBD as it looks to legalize the cannabis compound as food and drink additive

The U.S. FDA set May 31 as the first date for a hearing on CBD, as the government agency looks to potentially legalize the cannabis compound as an additive in food and drinks. (Getty Images/iStockphoto)

The U.S. FDA set May 31 as the first date for a hearing on CBD as the government agency looks to potentially legalize the cannabis compound as an additive in food and drinks.

At the meeting — which will take place at the agency’s headquarters in Silver Spring, Md. — the agency will obtain “scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale” of products that contain cannabis or cannabis-derived compounds, according to a document uploaded in the Federal Register Tuesday.

The public hearing will allow people to present data on the safety of the consumption and use of CBD.

In December last year, hemp — and any part or derivative of the plant — was legalized for sale in the U.S. This includes the compound CBD (cannabidiol).

Unlike THC (tetrahydrocannabinol), the compound CBD is not psychoactive and does not give users the feeling of being “high.” CBD has become known for its calming effects, with many users saying it helps them manage pain.

To Read The Rest Of This Article By Kassidy Vavra on NY Daily News

Published: April 02, 2019

SHARE
RELATED POSTS
Coachella By The Minute: Weekend 2
Council Approves Ballot Measure to Allow, Regulate Marijuana Sales in Pasadena
Kahner Global Cannabrunch: Plate Full of Investment Opportunities

Leave Your Reply

*